Letters: Unhealthy practice

Image
Business Standard New Delhi
Last Updated : May 30 2016 | 9:25 PM IST
With reference to "Only a price controller" (May 30), the editorial has rightly highlighted the sad state of affairs in our clueless department of pharmaceuticals. Its raison d'être is "to make available quality medicines at affordable prices". Period! Sadly, it is not even touching that subject. Everyone is aware that most medicine manufacturers give between 30 and 40 per cent discount on MRP to bulk buyers. Barring some chains offering a 10 per cent discount to senior citizens, none of this is passed on to customers. In fact in almost all hospitals even this 10 per cent is denied and all billing to all patients is at MRP. Why should there be such huge margins?

A major fault lies with the doctors prescribing only one "branded medicine" instead of mentioning the salt or suggesting alternatives. This is where the huge discounts presumably get spent - kickbacks to the practitioners prescribing a brand of their choice. In the UK, the doctors only prescribe a salt and it is left to the chemist to offer all alternatives to the patient - a healthy practice that has stood the test of time. There is also the huge unethical and corrupt sector of "fake" medicines, causing incalculable loss to patients including risk to lives. Not enough is being done by the department to check this, by way of imposing fines and awarding punishment to those engaged in this nefarious practice.

Krishan Kalra, Gurgaon

Letters can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201
E-mail: letters@bsmail.in
All letters must have a postal address and telephone number
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 30 2016 | 9:07 PM IST

Next Story